Von Willebrand's disease is the most frequent form among hereditary he
morrhagic diatheses characterized by autosomal-dominant and less frequ
ent resessive heredity. The disease is caused by quantitative or quali
tative defects of von Willebrand's plasmic factor which in hemostasis
functions as a protein-carrier of coagulation factor VIII and particip
ates in reactions of platelet interaction with damaged vascular wail a
t the stages of adhesion, spreading and aggregation of platelets. Von
Willebrand's disease presents with variable clinical and laboratory pa
rameters reflecting different disorders of the von Willebrand's factor
. This explains differential therapy of hemorrhagic syndrome.